The Food and Drug Administration is suspending “routine” food facility inspections in an effort to ensure the safety of its workforce and not interfere with food manufacturer programs to limit the number of visitors to their facilities in the wake of the coronavirus outbreak.
Other inspections deemed “mission critical” will continue.
“During this interim period, we’re evaluating additional ways to conduct our inspectional work that would not jeopardize public safety and protecting both the firms and the FDA staff,” said Stephen M. Hahn, MD, commissioner of food and drugs for the FDA. “This can include, among other things, evaluating records in lieu of conducting an onsite inspection on an interim basis when travel is not permissible, when appropriate.”
Dr. Hahn noted that during the past fiscal year the domestic violation rate among FDA-regulated companies was 5%.
“From our experience across the agency, we also believe FDA-regulated firms understand and appreciate their shared responsibility to ensure the integrity of the supply chain and we will continue to communicate with them during this time to underscore this partnership,” he said.
By Keith Nunes
Source: Food Business News
Consumer healthcare firm Haleon has appointed Tate & Lyle executive Dawn Allen as its new chief financial officer, effective 1 November 2024. Allen will succeed Tobias Hestler, who has decided to step down from the role, citing a long-term health condition, the company said.
The group said that the bottling line, which adds 6,500 square metres to the existing 60,700-square-metre site, is the next necessary stage in the company’s international development. The leading brand in Campari Group’s global sales, demand for the Italian bitter apéritif has grown by 500% in the last decade.
The partnership will see Coca-Cola adopt new technology to foster innovation and productivity globally. Through the deal, Coca-Cola has made a $1.1 billion commitment to the Microsoft Cloud and its generative AI capabilities.
